AssureRx News

AssureRx Adds VP of Operations and Technology
Tuesday 07/15/2008

Cincinnati, Ohio, July 15, 2008 - AssureRx LLC, a Personalized Medicine company, announced that Don Wright has joined the Company as Vice President of Operations and Technology.  He will be responsible for bringing the AssureRx products to market by managing the development of the web-based software applications, overseeing the company's molecular genetics lab operations, as well as building the client services and quality assurance organizations.

Wright brings over 20 years of product development and operations expertise gained with companies such as Attachmate, Spotlight Solutions, ProfitLogic and Domin-8 Enterprise Solutions. In his many roles with those companies he participated in over 25 successful product launches and played key leadership roles in planning and building the companies from early stage to market leading, international organizations. Most recently Wright helped to found and served as CTO of SaaS Capital, a finance company specializing in the SaaS software industry.  Prior to SaaS Capital, he served as the CIO and vice president of products for Domin-8 Enterprise Solutions.  In addition to his other responsibilities, Don oversaw the design and development of the company's web based product offerings. During this time the company grew from less than fifty thousand units under management to well over six million. Before Domin-8, Wright was the CTO and vice president of products for Spotlight Solutions, a leading provider of retail pricing and revenue optimization software.   After successfully managing the redesign of the Spotlight product suite he assisted in the company's merger with ProfitLogic; the combined company was eventually sold to Oracle Corporation.   Prior to this, Wright was vice president of product development at Attachmate, where he led the creation and support of a $450 million product line. He has also served at the AT&T Corporation as a systems designer, and at Lehr Precision as a software engineer.